News & Updates
The latest news and advances from the world's most exciting life science cluster.
Seattle biotech startup led by Fred Hutch, Adaptive vets raises $16M for rapid drug development tech
Investment into the Seattle biotech scene continues as Lumen Bioscience announced it received $16 million in Series B funding. The startup, led by former Adaptive
Athira Pharma, which develops therapies for brain diseases such as Alzheimer’s and Parkinson’s, filed for an IPO last week. Athira’s regenerative technology works to rebuild
Nanodropper, a medical device startup launched by a group of University of Washington students, announced that it received $500,000 in funding from the United States
Bristol Myers Squibb announced that it will commit $300 million over the next five years to tackle racial health disparities and accelerate its diversity and
Life Science Washington announced the launch of its new campaign, “Find Your Best Life in Washington,” to encourage top talent nationwide to learn more about